FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Thursday

 

New step toward determining the cause of MS.



























Demyelination by MS. The CD68 colored tissue shows several macrophages in the area of the lesion. Original scale 1:100. Credit: Marvin 101/Wikipedia

Researchers at the University of Toronto have found another clue in understanding the cause of what drives Multiple Sclerosis (MS) disease. Their findings were published today in Immunity.

MS is a disorder in which the immune system attacks the brain. It has no known cause and no cure. Normally, immune responses are triggered in lymph nodes and other lymphoid organs to protect us from a virus or pathogen. However, scientists have observed that a type of white blood cell known as lymphocytes can sometimes congregate into so-called "tertiary lymphoid tissues (TLTs)" in the brain of MS patients. These structures are similar to lymph nodes, but are found within the outer membrane of the brain - known as the meninges. They often coincide with the appearance of tell-tale brain inflammation associated with progressive MS. But how the TLTs are formed and what keeps them there has been unclear.

The U of T researchers, led by Professor Jen Gommerman of the Department of Immunology, discovered that TLTs were created by the presence of stromal cells, which are specialized cells that produce an intricate network of fibres. They can effectively create a net, which once formed, become a gathering place for a type of T cell known as T helper 17 cell (or Th17).

"While T cells are an important part of the body's ability to ward off infection and disease, in autoimmune disorders, they can mistake healthy tissue for potential threats and respond by lashing out, causing damage. The team observed that this Th17 response resulted in the type of brain tissue inflammation associated with MS," says Gommerman.

More than that, the Th17 cells could also influence how the stromal cells organized. The resulting structure that developed was remarkably similar to normal lymphatic tissue, such as you might find in your tonsils or lymph nodes in your neck.

Gommerman says this research, which was conducted using animal modeling, doesn't deliver a definitive answer to what causes MS, but it does appear to be a "smoking gun" associated with MS pathology. With further research, it may point to potential treatment options, such as targeted Th17 blockers.

Story Source: The above story is based on materials provided by MEDICALXPRESS
Note: Materials may be edited for content and length


Go to Newer News Go to Older News